Quality of life of patients with non-alcoholic fatty liver disease with different thyroid status-Reference-Cited by-同舟云学术

Quality of life of patients with non-alcoholic fatty liver disease with different thyroid status

Published:2021-12-18 Issue:35 Volume: Page:57-61
ISSN:2078-5631
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Chernyadeva E. V.¹^ORCID,Shklyaev A. E.²

Affiliation:

1. City Clinical Hospital No. 9

2. Izhevsk State Medical Academy

Abstract

The aim. To study the quality of life and psychoemotional state of patients with non-alcoholic fatty liver disease against the background of primary hypothyroidism during the use of ethylmethylhydroxypyridine succinate.Materials and methods. 111 patients with non-alcoholic fatty liver were examined, among them 35 were without thyroid dysfunction, 55 with compensated primary hypothyroidism, 21 with decompensated hypothyroidism. The patients underwent general clinical, biochemical, enzyme-linked immunosorbent assays of blood, instrumental studies, testing according to psychological questionnaires.Results. With decompensation of hypothyroidism, a statistically significant increase in indicators of depression, situational and personal anxiety was revealed in comparison with patients without hypothyroidism. The examined patients showed an increase in the level of situational and personal anxiety. The presence of hypothyroidism in the examined patients significantly worsens these indicators, leading to an increase in the degree of anxiety, aggravated by decompensation of hypothyroidism. A positive dynamic was revealed in the correction of the psychoemotional status of patients in the observation group during the complex treatment with ethylmethylhydroxypyridine succinate: the severity of depression, situational and personal anxiety, manifestations of dyspeptic and reflux syndromes decreased.Conclusion. Hypothyroidism affects the quality of life and psycho-emotional state of patients with non-alcoholic fatty liver disease: it worsens the degree of depression, situational and personal anxiety. The addition of ethylmethylhydroxypyridine succinate to standard therapy with sodium levothyroxine in patients with non-alcoholic fatty liver disease in the setting of hypothyroidism improves the quality of life and psycho-emotional state.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference8 articles.

1. Balukova E. V. Non-alcoholic fatty liver disease: current state of the problem. E. V. Balukova, N. V. Baryshnikova, L. N. Belousova. Рharmateca. 2016. No. 2 (315). P. 63–68.

2. Lazebnik L. B. Non-alcoholic fatty liver disease in adults: clinical picture, diagnosis, treatment. Recommendations for therapists, the third version. L. B. Lazebnik, E. V. Golovanova, S. V. Turkina [and others]. Experimental and clinical gastroenterology. 2021. No. 1 (185). P. 4–52. DOI: 10.31146.1682–8658-ecg-185–1–4–52.

3. Brus T. V. Endothelial dysfunction in non-alcoholic fatty liver disease. T. V. Brus, A. A. Kravсova. Children's medicine of the North-West. 2018. V. 7. No. 1. P. 47.

4. Vakhrushev Ya. M. Аssessment of the functional state of the small intestine in patients with non-alcoholic fatty liver disease. Ya. M. Vakhrushev, A. P. Lukashevich. The Russian Archives of Internal Medicine. 2020. V. 10. No. 6 (56). P. 468–474.

5. Shklyaev A. E. Dynamics of the quality of life of patients with the syndrome irritable bowel during drug and non-drug therapy. A. E. Shklyaev, A. S. Pantjuhina, Yu. V. Gorbunov. The Russian Archives of Internal Medicine. 2015. No. 2 (22). P. 45–48.